Related Experiment Video
Updated: Sep 14, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Transformation-associated changes in gene expression of alternative splicing regulatory factors in mouse fibroblast
1Department of Radiology and Radiation Oncology, Osaka University Graduate School of Dentistry, Osaka, Japan. tmaeda@radiol.dent.osaka-u.ac.jp
Abstract:
Although the alternative splicing of various genes is a common phenomenon in tumorigenesis, little is known about the mechanism behind it. Recently, we found altered expression of splicing regulatory factors during two-step chemical transformation in vitro. However, it remains unknown whether such altered expression of splicing factors commonly occur during other modes of transformation. We have further investigated the expression of five splicing regulatory factors, heterogeneous nuclear ribonucleoprotein (hnRNP) A1 and A2, alternative splicing factor/splicing factor 2 (ASF/SF2), spliceosome component of 35-kDa protein (SC35) and 65-kDa subunit of U2 snRNP auxiliary factor (U2AF65), using two series of clonally-derived mouse fibroblast cell lines, that were SV40 large T transfectants (SV-T2 and NIH3T3/13C7) or c-erbB2 transfectants (A4). U2AF65 expression was increased (2.1- and 2.7-fold) in NIH3T3/13C7 and A4 compared with the normal parental cells, respectively, and SC35 expression was increased 1.8- to 2.3-fold in all transformed cells. These results suggest that altered expression of some splicing regulatory factors may commonly occur during various modes of cellular transformation.
Insights
Altered expression of splicing regulatory factors, such as U2AF65 and SC35, is common in cellular transformation. This suggests a widespread role for splicing factor dysregulation in cancer development.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Alternative splicing is crucial in tumorigenesis, but its regulatory mechanisms are not fully understood.
- Previous studies indicated altered splicing factor expression during chemical transformation.
- The commonality of this phenomenon across different transformation modes remained unclear.
Purpose of the Study:
- To investigate the expression of five key splicing regulatory factors in mouse fibroblast cell lines undergoing different transformation processes.
- To determine if altered splicing factor expression is a common event in cellular transformation.
Main Methods:
- Utilized clonally-derived mouse fibroblast cell lines: SV40 large T transfectants (SV-T2, NIH3T3/13C7) and c-erbB2 transfectants (A4).
- Quantified the expression levels of heterogeneous nuclear ribonucleoprotein (hnRNP) A1 and A2, alternative splicing factor/splicing factor 2 (ASF/SF2), spliceosome component of 35-kDa protein (SC35), and 65-kDa subunit of U2 snRNP auxiliary factor (U2AF65).
Main Results:
- U2AF65 expression increased 2.1- and 2.7-fold in NIH3T3/13C7 and A4 cells, respectively, compared to parental cells.
- SC35 expression showed a significant increase (1.8- to 2.3-fold) across all tested transformed cell lines.
- hnRNP A1, hnRNP A2, and ASF/SF2 expression patterns were not detailed in the abstract.
Conclusions:
- Altered expression of specific splicing regulatory factors, including U2AF65 and SC35, is a common occurrence during various modes of cellular transformation.
- These findings suggest a potentially general role for dysregulated splicing factor expression in the development of cancer.
Related Concept Videos
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Master Transcription Regulators
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Somatic to iPS Cell Reprogramming
Forced Transdifferentiation
Artificial transdifferentiation occurs...

